These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15799682)

  • 21. Inadequacies of statutory drug compendia also affect the mental health field.
    Paczynski RP; Kruszewski SP
    Ann Intern Med; 2009 Sep; 151(5):364-5. PubMed ID: 19721028
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of personal digital assistant software for drug interactions.
    Barrons R
    Am J Health Syst Pharm; 2004 Feb; 61(4):380-5. PubMed ID: 15011766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diminishing value of the Physicians' Desk Reference and drug package inserts as a medical and legal standard of medical usage of pharmaceutical drugs.
    Burkhart CG
    J Drugs Dermatol; 2005; 4(4):414-5. PubMed ID: 16004013
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of the consistency among three drug compendia in listing and ranking of drug-drug interactions.
    Nikolić BS; Ilić MS
    Bosn J Basic Med Sci; 2013 Nov; 13(4):253-8. PubMed ID: 24289762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
    Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
    J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What information is given on adverse drug reactions from new drugs?].
    Eldholm RS; Bergheim TS; Slørdal L; Spigset O
    Tidsskr Nor Laegeforen; 2003 Sep; 123(17):2414-7. PubMed ID: 14562773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Physicians' Desk Reference should not be held as a legal standard of medical care.
    Burkhart CG; Burkhart KM; Burkhart AK
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):609-10. PubMed ID: 9641723
    [No Abstract]   [Full Text] [Related]  

  • 29. Implementing a Process to Review Product-Specific Misinformation in Online Drug Information Compendia.
    Talwar SR; Crudele NT; Dankiewicz EH; Randhawa AS; Haddox JD
    Ther Innov Regul Sci; 2015 Mar; 49(2):262-268. PubMed ID: 30222421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug formulary review process for sargramostim and filgrastim: focus on analysis of adverse drug reactions.
    Kellihan MJ
    Clin Ther; 1993; 15(5):927-37. PubMed ID: 7505717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What clinical information resources are available in family physicians' offices?
    Ely JW; Levy BT; Hartz A
    J Fam Pract; 1999 Feb; 48(2):135-9. PubMed ID: 10037545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Collaborative Assessment Among 11 Pharmaceutical Companies of Misinformation in Commonly Used Online Drug Information Compendia.
    Randhawa AS; Babalola O; Henney Z; Miller M; Nelson T; Oza M; Patel C; Randhawa AS; Riley J; Snyder S; So S
    Ann Pharmacother; 2016 May; 50(5):352-9. PubMed ID: 26917822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antineoplastic agents: comparing off-label uses among authoritative drug compendia.
    Thompson DF; Keefe CC
    Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of consumer drug information databases.
    Choi JA; Sullivan J; Pankaskie M; Brufsky J
    J Am Pharm Assoc (Wash); 1999; 39(5):683-7. PubMed ID: 10533350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.
    Scheife RT; Hines LE; Boyce RD; Chung SP; Momper JD; Sommer CD; Abernethy DR; Horn JR; Sklar SJ; Wong SK; Jones G; Brown ML; Grizzle AJ; Comes S; Wilkins TL; Borst C; Wittie MA; Malone DC
    Drug Saf; 2015 Feb; 38(2):197-206. PubMed ID: 25556085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One more case of the double standard: discrepancies between drug information provided to Brazilian and American physicians.
    de Barros JA
    Pharmacoepidemiol Drug Saf; 2000 Jul; 9(4):281-7. PubMed ID: 19025829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a questionnaire for detecting potential adverse drug reactions.
    Corso DM; Pucino F; DeLeo JM; Calis KA; Gallelli JF
    Ann Pharmacother; 1992; 26(7-8):890-6. PubMed ID: 1504394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.